» Articles » PMID: 28206648

Knowledge About the Presence or Absence of MiRNA Isoforms (isomiRs) Can Successfully Discriminate Amongst 32 TCGA Cancer Types

Overview
Specialty Biochemistry
Date 2017 Feb 17
PMID 28206648
Citations 115
Authors
Affiliations
Soon will be listed here.
Abstract

Isoforms of human miRNAs (isomiRs) are constitutively expressed with tissue- and disease-subtype-dependencies. We studied 10 271 tumor datasets from The Cancer Genome Atlas (TCGA) to evaluate whether isomiRs can distinguish amongst 32 TCGA cancers. Unlike previous approaches, we built a classifier that relied solely on 'binarized' isomiR profiles: each isomiR is simply labeled as 'present' or 'absent'. The resulting classifier successfully labeled tumor datasets with an average sensitivity of 90% and a false discovery rate (FDR) of 3%, surpassing the performance of expression-based classification. The classifier maintained its power even after a 15× reduction in the number of isomiRs that were used for training. Notably, the classifier could correctly predict the cancer type in non-TCGA datasets from diverse platforms. Our analysis revealed that the most discriminatory isomiRs happen to also be differentially expressed between normal tissue and cancer. Even so, we find that these highly discriminating isomiRs have not been attracting the most research attention in the literature. Given their ability to successfully classify datasets from 32 cancers, isomiRs and our resulting 'Pan-cancer Atlas' of isomiR expression could serve as a suitable framework to explore novel cancer biomarkers.

Citing Articles

Re-Analyses of Samples From Amyotrophic Lateral Sclerosis Patients and Controls Identify Many Novel Small RNAs With Diagnostic And Prognostic Potential.

Loher P, Londin E, Ilieva H, Pasinelli P, Rigoutsos I Mol Neurobiol. 2025; .

PMID: 39982687 DOI: 10.1007/s12035-025-04747-2.


Spatial miRNomics: towards the integration of microRNAs in spatial biology.

Robles-Remacho A, Nilsson M Nat Rev Genet. 2025; .

PMID: 39915688 DOI: 10.1038/s41576-025-00819-0.


The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma.

Koumpis E, Georgoulis V, Papathanasiou K, Papoudou-Bai A, Kanavaros P, Kolettas E Biomedicines. 2025; 12(12.

PMID: 39767565 PMC: 11673977. DOI: 10.3390/biomedicines12122658.


Comprehensive profiling of small RNAs and their changes and linkages to mRNAs in schizophrenia and bipolar disorder.

Nersisyan S, Loher P, Nazeraj I, Shao Z, Fullard J, Voloudakis G bioRxiv. 2025; .

PMID: 39763727 PMC: 11703252. DOI: 10.1101/2024.12.24.630254.


Click chemistry-based dual nanosystem for microRNA-122 detection with single-base specificity from tumour cells.

Robles-Remacho A, Martos-Jamai I, Tabraue-Chavez M, Aguilar-Gonzalez A, Laz-Ruiz J, Cano-Cortes M J Nanobiotechnology. 2024; 22(1):791.

PMID: 39710710 PMC: 11665063. DOI: 10.1186/s12951-024-03071-6.


References
1.
Davis C, Ricketts C, Wang M, Yang L, Cherniack A, Shen H . The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014; 26(3):319-330. PMC: 4160352. DOI: 10.1016/j.ccr.2014.07.014. View

2.
Shmulevich I, Zhang W . Binary analysis and optimization-based normalization of gene expression data. Bioinformatics. 2002; 18(4):555-65. DOI: 10.1093/bioinformatics/18.4.555. View

3.
Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A . A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129(7):1401-14. PMC: 2681231. DOI: 10.1016/j.cell.2007.04.040. View

4.
Su Y, Wu H, Pavlosky A, Zou L, Deng X, Zhang Z . Regulatory non-coding RNA: new instruments in the orchestration of cell death. Cell Death Dis. 2016; 7(8):e2333. PMC: 5108314. DOI: 10.1038/cddis.2016.210. View

5.
Edelstein L, McKenzie S, Shaw C, Holinstat M, Kunapuli S, Bray P . MicroRNAs in platelet production and activation. J Thromb Haemost. 2013; 11 Suppl 1:340-50. DOI: 10.1111/jth.12214. View